Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Emily Z, Keung"'
Autor:
Prapassorn Thirasastr, Heather Lin, Behrang Amini, Wei‐Lien Wang, Jeffrey M. Cloutier, Elise F. Nassif, Emily Z. Keung, Christina L. Roland, Barry Feig, Dejka Araujo, Robert S. Benjamin, Anthony P. Conley, John A. Livingston, Joseph Ludwig, Shreyaskumar Patel, Ravin Ratan, Vinod Ravi, Maria Alejandra Zarzour, Xiao Zhou, Neeta Somaiah
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4282-4293 (2023)
Abstract Objective Well‐differentiated (WDLPS) and dedifferentiated liposarcoma (DDLPS) account for the majority of liposarcomas. Although gemcitabine‐docetaxel is used as second‐line treatment in soft tissue sarcomas, its efficacy in WDLPS/DDL
Externí odkaz:
https://doaj.org/article/67794b3693904079b386d4390d2378fa
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 2144-2158 (2023)
Significant multidisciplinary scientific effort has been undertaken to understand the heterogeneous family of neoplasms that comprise soft tissue sarcomas. Within this family of neoplasms, outcomes for retroperitoneal sarcomas (RPS) are currently lim
Externí odkaz:
https://doaj.org/article/1af4b4e4c7434bd9b2003322a31252a4
Autor:
Irantzu Anzar, Brandon Malone, Pubudu Samarakoon, Ioannis Vardaxis, Boris Simovski, Hugues Fontenelle, Leonardo A. Meza-Zepeda, Richard Stratford, Emily Z. Keung, Melissa Burgess, Hussein A. Tawbi, Ola Myklebost, Trevor Clancy
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionSarcomas are comprised of diverse bone and connective tissue tumors with few effective therapeutic options for locally advanced unresectable and/or metastatic disease. Recent advances in immunotherapy, in particular immune checkpoint inhi
Externí odkaz:
https://doaj.org/article/53e7fb56ac8c4288a24bd58dd3d4124a
Autor:
Timothy P. DiPeri, MD, Timothy E. Newhook, MD, Ryan W. Day, MD, Yi-Ju Chiang, MSPH, Whitney L. Dewhurst, MS, AGNP-C, Elsa M. Arvide, MS, PA-C, Morgan L. Bruno, MS, ACNP-BC, Christopher P. Scally, MD, MS, Christina L. Roland, MD, MS, Matthew H.G. Katz, MD, Jean-Nicolas Vauthey, MD, George J. Chang, MD, MS, Brian D. Badgwell, MD, MS, Nancy D. Perrier, MD, Elizabeth G. Grubbs, MD, Jeffrey E. Lee, MD, Ching-Wei D. Tzeng, MD, Brian K. Bednarski, MD, Iris B. Chen, MS, APRN, Ryan J. Comeaux, MS, PA-C, Dana M. Cox, MPAS, PA-C, Barry W. Feig, MD, Sarah B. Fisher, MD, Keith F. Fournier, MD, Semhar J. Ghebremichael, MD, Heather M. Gibson, MS, PA-C, Nicole C. Gourmelon, MS, PA-C, Paul H. Graham, MD, Shannon Hancher, MD, Kelly K. Hunt, MD, Naruhiko Ikoma, MD, MPH, Shanae L. Ivey MPAS, PA-C, Emily Z. Keung, MD, Celia R. Ledet, MD, Angela R. Limmer, MS, PA-C, Paul F. Mansfield, MD, Lauren K. Mayon, MS, PA-C, Craig A. Messick, MD, Keyuri U. Popat, MD, Nikita F. Rajkot MPAS, PA-C, Justine L. Robinson MPAS, PA-C, Kristen A. Robinson MPAS, PA-C, Miguel A. Rodriguez-Bigas, MD, David A. Santos, MD, MS, John M. Skibber, MD, B. Bryce Speer, DO, Jose Soliz, MD, Matthew M. Tillman, MD, Keila E. Torres, MD, Antoinette van Meter, MD, Marla E. Weldon, MS, PA-C, Uduak Ursula Williams, MD, Y. Nancy You, MD, MHSc
Publikováno v:
Surgery Open Science, Vol 9, Iss , Pp 51-57 (2022)
Background: We designed a prospective feasibility study to assess the 5x-multiplier (5x) calculation (eg, 3 pills in last 24 hours × 5 = 15) to standardize discharge opioid prescriptions compared to usual care. Methods: Faculty-based surgical teams
Externí odkaz:
https://doaj.org/article/eb76d169a7434c548f83e4fa72a03946
Autor:
Raymond S. Traweek, Brandon M. Cope, Christina L. Roland, Emily Z. Keung, Elise F. Nassif, Derek J. Erstad
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Dedifferentiated liposarcoma (DDLPS) is an aggressive adipogenic cancer with poor prognosis. DDLPS tumors are only modestly sensitive to chemotherapy and radiation, and there is a need for more effective therapies. Genetically, DDLPS is characterized
Externí odkaz:
https://doaj.org/article/4a9fcb3f4db2496ead212f8dd89e9ca6
Autor:
Joel Ho, Jane Mattei, Michael Tetzlaff, Michelle D. Williams, Michael A. Davies, Adi Diab, Isabella C. Glitza Oliva, Jennifer McQuade, Sapna P. Patel, Hussein Tawbi, Michael K. Wong, Sarah B. Fisher, Ehab Hanna, Emily Z. Keung, Merrick Ross, Roi Weiser, Shirley Y. Su, Michael Frumovitz, Larissa A. Meyer, Amir Jazaeri, Curtis A. Pettaway, B. Ashleigh Guadagnolo, Andrew J. Bishop, Devarati Mitra, Ahsan Farooqi, Roland Bassett, Silvana Faria, Priyadharsini Nagarajan, Rodabe N. Amaria
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundNeoadjuvant checkpoint inhibition (CPI) has recently demonstrated impressive outcomes in patients with stage 3 cutaneous melanoma. However, the safety, efficacy, and outcome of neoadjuvant CPI in patients with mucosal melanoma (MM) are not
Externí odkaz:
https://doaj.org/article/130631cb682140daaa725bf5649ba720
Autor:
Rossana Lazcano, Carmelia M. Barreto, Ruth Salazar, Fernando Carapeto, Raymond S. Traweek, Cheuk H. Leung, Swati Gite, Jay Mehta, Davis R. Ingram, Khalida M. Wani, Kim-Anh T. Vu, Edwin R. Parra, Wei Lu, Jianling Zhou, Russell G. Witt, Brandon Cope, Prapassorn Thirasastr, Heather Y. Lin, Christopher P. Scally, Anthony P. Conley, Ravin Ratan, J. Andrew Livingston, Alexandra M. Zarzour, Joseph Ludwig, Dejka Araujo, Vinod Ravi, Shreyaskumar Patel, Robert Benjamin, Jennifer Wargo, Ignacio I. Wistuba, Neeta Somaiah, Christina L. Roland, Emily Z. Keung, Luisa Solis, Wei-Lien Wang, Alexander J. Lazar, Elise F. Nassif
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionUndifferentiated pleomorphic sarcoma (UPS) can be associated with a relatively dense immune infiltration. Immune checkpoint inhibitors (anti-PD1, anti-PDL1, and anti-CTLA4) are effective in 20% of UPS patients. We characterize the immune
Externí odkaz:
https://doaj.org/article/0f3178fc4ae44b07859cc53a24e0f97e
Autor:
David Boyce-Fappiano, MD, MHM, Ethan P. Damron, BS, Ahsan Farooqi, MD, PhD, Devarati Mitra, MD, PhD, Anthony P. Conley, MD, Neeta Somaiah, MD, Dejka M. Araujo, MD, J. Andrew Livingston, MD, Ravin Ratan, MD, MEd, Emily Z. Keung, MD, Christina L. Roland, MD, MS, B. Ashleigh Guadagnolo, MD, MPH, Andrew J. Bishop, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 3, Pp 100913- (2022)
Purpose: Given the relative radioresistance of sarcomas and their often large size, conventional palliative radiation therapy (RT) often offers limited tumor control and symptom relief. We report on our use of hypofractionated RT (HFRT) as a strategy
Externí odkaz:
https://doaj.org/article/a0629367718743a7b71fcc247c10ac46
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: COVID-19 is associated with immune dysregulation which may increase susceptibility to atypical infectious diseases, particularly in the vulnerable cancer patient population. Coccidioidomycosis is an endemic fungal infection which presen
Externí odkaz:
https://doaj.org/article/a8aa068c42814c75a5c0c05ca0d9281c
Autor:
Russell G. Witt, Rachel K. Voss, Yi-Ju Chiang, Sa Nguyen, Christopher P. Scally, Patrick P. Lin, Keila E. Torres, Bryan S. Moon, Robert L. Satcher, Kelly K. Hunt, Justin E. Bird, Barry W. Feig, Valerae O. Lewis, Christina L. Roland, Emily Z. Keung
Publikováno v:
Annals of Surgical Oncology. 30:3668-3676